257 related articles for article (PubMed ID: 28694326)
21. Oncogenically active MYD88 mutations in human lymphoma.
Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
[TBL] [Abstract][Full Text] [Related]
22. Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.
Kohnken R; Wen J; Mundy-Bosse B; McConnell K; Keiter A; Grinshpun L; Hartlage A; Yano M; McNeil B; Chakravarti N; William B; Bradner JE; Caligiuri MA; Porcu P; Mishra A
Blood; 2018 Feb; 131(7):771-781. PubMed ID: 29180399
[TBL] [Abstract][Full Text] [Related]
23. Sam68 modulates the promoter specificity of NF-κB and mediates expression of CD25 in activated T cells.
Fu K; Sun X; Zheng W; Wier EM; Hodgson A; Tran DQ; Richard S; Wan F
Nat Commun; 2013; 4():1909. PubMed ID: 23715268
[TBL] [Abstract][Full Text] [Related]
24. Constitutive expression of NF-kappa B is a characteristic feature of mycosis fungoides: implications for apoptosis resistance and pathogenesis.
Izban KF; Ergin M; Qin JZ; Martinez RL; Pooley RJ JR; Saeed S; Alkan S
Hum Pathol; 2000 Dec; 31(12):1482-90. PubMed ID: 11150373
[TBL] [Abstract][Full Text] [Related]
25. A novel splice variant of the Fas gene in patients with cutaneous T-cell lymphoma.
van Doorn R; Dijkman R; Vermeer MH; Starink TM; Willemze R; Tensen CP
Cancer Res; 2002 Oct; 62(19):5389-92. PubMed ID: 12359741
[TBL] [Abstract][Full Text] [Related]
26. Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma.
Yumeen S; Girardi M
Yale J Biol Med; 2020 Mar; 93(1):111-121. PubMed ID: 32226341
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase C-δ negatively regulates T cell receptor-induced NF-κB activation by inhibiting the assembly of CARMA1 signalosome.
Liu Y; Song R; Gao Y; Li Y; Wang S; Liu HY; Wang Y; Hu YH; Shu HB
J Biol Chem; 2012 Jun; 287(24):20081-7. PubMed ID: 22528498
[TBL] [Abstract][Full Text] [Related]
28. Phosphorylation of Carma1, but not Bcl10, by Akt regulates TCR/CD28-mediated NF-κB induction and cytokine production.
Cheng J; Hamilton KS; Kane LP
Mol Immunol; 2014 May; 59(1):110-6. PubMed ID: 24548923
[TBL] [Abstract][Full Text] [Related]
29. Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival.
Bidère N; Ngo VN; Lee J; Collins C; Zheng L; Wan F; Davis RE; Lenz G; Anderson DE; Arnoult D; Vazquez A; Sakai K; Zhang J; Meng Z; Veenstra TD; Staudt LM; Lenardo MJ
Nature; 2009 Mar; 458(7234):92-6. PubMed ID: 19118383
[TBL] [Abstract][Full Text] [Related]
30. Preclinical Targeting of MicroRNA-214 in Cutaneous T-Cell Lymphoma.
Kohnken R; McNeil B; Wen J; McConnell K; Grinshpun L; Keiter A; Chen L; William B; Porcu P; Mishra A
J Invest Dermatol; 2019 Sep; 139(9):1966-1974.e3. PubMed ID: 30876800
[TBL] [Abstract][Full Text] [Related]
31. Methods to Study CARD11-BCL10-MALT1 Dependent Canonical NF-κB Activation in Jurkat T Cells.
Gewies A; Graß C; Krappmann D
Methods Mol Biol; 2021; 2366():125-143. PubMed ID: 34236636
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides.
van Kester MS; Borg MK; Zoutman WH; Out-Luiting JJ; Jansen PM; Dreef EJ; Vermeer MH; van Doorn R; Willemze R; Tensen CP
J Invest Dermatol; 2012 Aug; 132(8):2050-9. PubMed ID: 22513784
[TBL] [Abstract][Full Text] [Related]
33. Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathways.
Pérez C; Mondéjar R; García-Díaz N; Cereceda L; León A; Montes S; Durán Vian C; Pérez Paredes MG; González-Morán A; Alegre de Miguel V; Sanz Anquela JM; Frias J; Limeres MA; González LM; Martín Dávila F; Beltrán M; Mollejo M; Méndez JR; González MA; González García J; López R; Gómez A; Izquierdo F; Ramos R; Camacho C; Rodriguez-Pinilla SM; Martínez N; Vaqué JP; Ortiz-Romero PL; Piris MA
Br J Dermatol; 2020 Jan; 182(1):147-155. PubMed ID: 31049933
[TBL] [Abstract][Full Text] [Related]
34. Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.
Chang TP; Poltoratsky V; Vancurova I
J Immunol; 2015 Mar; 194(6):2942-53. PubMed ID: 25681335
[TBL] [Abstract][Full Text] [Related]
35. TCR-CXCR4 signaling stabilizes cytokine mRNA transcripts via a PREX1-Rac1 pathway: implications for CTCL.
Kremer KN; Dinkel BA; Sterner RM; Osborne DG; Jevremovic D; Hedin KE
Blood; 2017 Aug; 130(8):982-994. PubMed ID: 28694325
[TBL] [Abstract][Full Text] [Related]
36. Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma.
Fujisawa M; Sakata-Yanagimoto M; Nishizawa S; Komori D; Gershon P; Kiryu M; Tanzima S; Fukumoto K; Enami T; Muratani M; Yoshida K; Ogawa S; Matsue K; Nakamura N; Takeuchi K; Izutsu K; Fujimoto K; Teshima T; Miyoshi H; Gaulard P; Ohshima K; Chiba S
Leukemia; 2018 Mar; 32(3):694-702. PubMed ID: 28832024
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
Edelson RL
Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
[TBL] [Abstract][Full Text] [Related]
38. Branched evolution and genomic intratumor heterogeneity in the pathogenesis of cutaneous T-cell lymphoma.
Iyer A; Hennessey D; O'Keefe S; Patterson J; Wang W; Wong GK; Gniadecki R
Blood Adv; 2020 Jun; 4(11):2489-2500. PubMed ID: 32502269
[TBL] [Abstract][Full Text] [Related]
39. Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma.
Froehlich TC; Müller-Decker K; Braun JD; Albrecht T; Schroeder A; Gülow K; Goerdt S; Krammer PH; Nicolay JP
Blood; 2019 Aug; 134(5):445-455. PubMed ID: 31167801
[TBL] [Abstract][Full Text] [Related]
40. Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways.
Patil K; Kuttikrishnan S; Khan AQ; Ahmad F; Alam M; Buddenkotte J; Ahmad A; Steinhoff M; Uddin S
Semin Cancer Biol; 2022 Nov; 86(Pt 3):382-399. PubMed ID: 34906723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]